Tocilizumab versus the Covid19 tempest: All's well that ends well or much ado about nothing?
作者信息
Lee Todd C, Butler-Laporte Guillaume, Chagla Zain, McDonald Emily G
机构信息
Clinical Practice Assessment Unit, Department of Medicine, McGill University, Montréal, Canada; Division of General Internal Medicine, Department of Medicine, McGill University, Montréal, Canada; Division of Infectious Diseases, Department of Medicine, McGill University, Montréal, Canada.
Division of Infectious Diseases, Department of Medicine, McGill University, Montréal, Canada.
出版信息
Clin Microbiol Infect. 2021 Feb;27(2):158-159. doi: 10.1016/j.cmi.2020.09.033. Epub 2020 Sep 29.
Abstract
摘要
相似文献
1
Tocilizumab versus the Covid19 tempest: All's well that ends well or much ado about nothing?托珠单抗与新冠疫情风暴：结局好就一切都好还是无事生非？
Clin Microbiol Infect. 2021 Feb;27(2):158-159. doi: 10.1016/j.cmi.2020.09.033. Epub 2020 Sep 29.
2
Breast cancer screening: all's well that ends well, or much ado about nothing?
AJR Am J Roentgenol. 1989 Apr;152(4):891. doi: 10.2214/ajr.152.4.891.
3
Anakinra after treatment with corticosteroids alone or with tocilizumab in patients with severe COVID‑19 pneumonia and moderate hyperinflammation. A retrospective cohort study: comment.在重症 COVID-19 肺炎和中度炎症反应患者中，单独使用皮质类固醇或与托珠单抗联合使用阿那白滞素后的情况。一项回顾性队列研究：评论
Intern Emerg Med. 2021 Jun;16(4):1101-1103. doi: 10.1007/s11739-021-02663-6. Epub 2021 Feb 18.
4
Anakinra after treatment with corticosteroids alone or with tocilizumab in patients with severe COVID‑19 pneumonia and moderate hyperinflammation. A retrospective cohort study: reply.在重度新型冠状病毒肺炎和中度炎症反应患者中，单用皮质类固醇或联合托珠单抗治疗后使用阿那白滞素：一项回顾性队列研究：回复
Intern Emerg Med. 2021 Jun;16(4):1105-1106. doi: 10.1007/s11739-021-02690-3. Epub 2021 Mar 10.
5
Wendell G. Scott memorial lecture. Breast cancer screening: all's well that ends well, or much ado about nothing?
AJR Am J Roentgenol. 1988 Oct;151(4):659-65. doi: 10.2214/ajr.151.4.659.
6
Tocilizumab: From Rheumatic Diseases to COVID-19.托珠单抗：从风湿性疾病到 COVID-19。
Curr Pharm Des. 2021;27(13):1597-1607. doi: 10.2174/1381612827666210311141512.
7
Benign SARS-CoV-2 infection in MOG-antibodies associated disorder during tocilizumab treatment.托珠单抗治疗期间伴 MOG 抗体相关疾病的良性 SARS-CoV-2 感染。
Mult Scler Relat Disord. 2020 Nov;46:102592. doi: 10.1016/j.msard.2020.102592. Epub 2020 Oct 21.
8
Association of injection Tocilizumab and inflammatory markers in COVID19.COVID19 中注射托珠单抗与炎症标志物的关系。
J Assoc Physicians India. 2022 Apr;70(4):11-12.
9
Impact of Timing of Tocilizumab Use in Hospitalized Patients With SARS-CoV-2 Infection.COVID-19 住院患者使用托珠单抗时机的影响。
Respir Care. 2021 Dec;66(12):1805-1814. doi: 10.4187/respcare.08779. Epub 2021 Sep 21.
10
Tocilizumab administration in patients with SARS-CoV-2 infection: Subcutaneous injection vs intravenous infusion.托珠单抗用于严重急性呼吸综合征冠状病毒2（SARS-CoV-2）感染患者：皮下注射与静脉输注对比
J Med Virol. 2021 Jan;93(1):69-70. doi: 10.1002/jmv.26124. Epub 2020 Jun 19.
引用本文的文献
1
Assessment of Studies of Quality Improvement Strategies to Enhance Outcomes in Patients With Cardiovascular Disease.评估改善策略对心血管疾病患者结局影响的研究。
JAMA Netw Open. 2021 Jun 1;4(6):e2113375. doi: 10.1001/jamanetworkopen.2021.13375.
本文引用的文献
1
Effects of tocilizumab on mortality in hospitalized patients with COVID-19: a multicentre cohort study.托珠单抗对 COVID-19 住院患者死亡率的影响：一项多中心队列研究。
Clin Microbiol Infect. 2021 Feb;27(2):238-243. doi: 10.1016/j.cmi.2020.09.021. Epub 2020 Sep 23.
2
Efficacy of tocilizumab in COVID-19: A systematic review and meta-analysis.托珠单抗治疗 COVID-19 的疗效：系统评价和荟萃分析。
J Med Virol. 2021 Mar;93(3):1620-1630. doi: 10.1002/jmv.26509. Epub 2020 Sep 28.
3
The role of IL-6 and other mediators in the cytokine storm associated with SARS-CoV-2 infection.白细胞介素 6 及其他介质在与 SARS-CoV-2 感染相关的细胞因子风暴中的作用。
J Allergy Clin Immunol. 2020 Sep;146(3):518-534.e1. doi: 10.1016/j.jaci.2020.07.001.
4
Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19: A Meta-analysis.COVID-19 重症患者全身使用皮质类固醇与死亡率的关联：一项荟萃分析。
JAMA. 2020 Oct 6;324(13):1330-1341. doi: 10.1001/jama.2020.17023.
5
Treatment with tocilizumab or corticosteroids for COVID-19 patients with hyperinflammatory state: a multicentre cohort study (SAM-COVID-19).托珠单抗或皮质类固醇治疗伴有炎症过高状态的 COVID-19 患者：一项多中心队列研究（SAM-COVID-19）。
Clin Microbiol Infect. 2021 Feb;27(2):244-252. doi: 10.1016/j.cmi.2020.08.010. Epub 2020 Aug 27.
6
Methylprednisolone as Adjunctive Therapy for Patients Hospitalized With Coronavirus Disease 2019 (COVID-19; Metcovid): A Randomized, Double-blind, Phase IIb, Placebo-controlled Trial.甲泼尼龙辅助治疗 2019 年冠状病毒病（COVID-19；METCovid）住院患者：一项随机、双盲、IIb 期、安慰剂对照试验。
Clin Infect Dis. 2021 May 4;72(9):e373-e381. doi: 10.1093/cid/ciaa1177.
7
Dexamethasone in Hospitalized Patients with Covid-19.地塞米松在 COVID-19 住院患者中的应用。
N Engl J Med. 2021 Feb 25;384(8):693-704. doi: 10.1056/NEJMoa2021436. Epub 2020 Jul 17.
8
Is a "Cytokine Storm" Relevant to COVID-19?“细胞因子风暴”与新冠病毒病有关吗？
JAMA Intern Med. 2020 Sep 1;180(9):1152-1154. doi: 10.1001/jamainternmed.2020.3313.
9
Ventilation Techniques and Risk for Transmission of Coronavirus Disease, Including COVID-19: A Living Systematic Review of Multiple Streams of Evidence.通风技术与冠状病毒病（包括 COVID-19）传播风险：多种证据来源的实时系统评价。
Ann Intern Med. 2020 Aug 4;173(3):204-216. doi: 10.7326/M20-2306. Epub 2020 May 22.
10
Pneumonia of unknown aetiology in Wuhan, China: potential for international spread via commercial air travel.中国武汉不明原因肺炎：经商业航空旅行传播至国际的潜在风险。
J Travel Med. 2020 Mar 13;27(2). doi: 10.1093/jtm/taaa008.
Zotero 插件